Stocks to watch: Shares of firms like Vedanta, Infosys, Tata Steel, Paytm, ONGC, Adani Green, and others will be in focus on Friday’s trade.
Stocks To Watch on December 26: Nifty futures on the Gift Nifty traded 22 points 0.12% higher at 21,421 around 6.45 am on Tuesday, signalling a positive start for Dalal Street. Here are the top stocks that will likely remain in action today:
Vedanta: Vedanta arm Bharat Aluminium Co (BALCO) received Rs 84 crore GST demand from Bilaspur authorities for FY17-18 on account of various interpretational issues.
Read More: Motisons Jewellers IPO listing date tomorrow: Check GMP, return predictions and more
Infosys: A global company terminated the MOU for a $1.5 billion deal with Infosys. The MoU was signed to provide enhanced digital experiences, business operation services for the company.
Tata Steel: Tata Steel shareholders meeting will be held on January 25 to consider and approve the scheme of amalgamation amongst Tata Steel Limited and The Indian Steel and Wire Products.
Muthoot Microfin, Suraj Estate Developers: These two stocks will debut on the bourses today. The former was subscribed up to 11.5 times, while the latter 15.7 times.
Paytm: Changes in its business due to shifts in regulatory stance and the adoption of artificial intelligence have been responsible for the fintech major to rationalize its employee cost structure.
Read More: Muthoot Microfin IPO listing date: GMP shows jump, check share price predictions
Kalyan Jewellers: Incorporates a wholly-owned step-down subsidiary – Kalyan Jewellers Procurement LLC – in UAE.
Anupam Rasayan: Inks Letter of Intent worth Rs 507 crore with one of the leading Japanese Multi National Chemical company to supply new age polymer intermediate for the next 9 years.
Adani Green: Has inked a power purchase agreement (PPA) to supply 1,799 megawatts (Mw) of solar power with the Solar Energy Corporation of India (SECI). With this, Adani Green now has tied up PPAs of 19.8 Gw.
ONGC: The company’s wholly-owned overseas arm ONGC Videsh plans to raise up to Rs 5,000 crore through non-convertible debentures (NCDs) for funding capex, refinancing and operations.
Aurobindo Pharma: The company in an exchange filing said the United States Food and Drug Administration (US FDA) completed a Pre-Approval Inspection (PAI) at its new injectable facility in East Windsor, New Jersey. The inspection resulted in 10 observations, which are procedural in nature.
Adani Wilmar: Promoters will offload 1.24 per cent stake to comply with Sebi’s minimum public shareholding norms. The divestment is to be done by January 31, 2024.
Read More: Sachin Tendulkar, Infosys founder among buyers of FirstCry shares ahead of IPO launch
Biocon: The pharma company’s arm Biocon Biologics has partnered with Sandoz for the distribution, sale, and promotion of Adalimumab (a biosimilar version of the blockbuster drug Humira) in Japan.
Lupin: Lupin Atlantis Holdings, a wholly-owned subsidiary of Lupin, has signed an Asset Purchase Agreement with French-based Sanofi for acquisition of a portfolio of accretive established products in Europe and Canada. The brands AARANE in Germany and NALCROM in Canada and the Netherlands have a combined turnover of approximately $6.494 million (Rs 53.7 crore) for FY23.
DISCLAIMER:Disclaimer: The views and investment tips by experts in this News18.com report are their own and not those of the website or its management. Users are advised to check with certified experts before taking any investment decisions.
